Reuters logo
BRIEF-Critical Outcome Technologies announces pharmacokinetic data from phase 1 dose escalation portion of COTI-2 trial
November 15, 2017 / 12:18 PM / 3 days ago

BRIEF-Critical Outcome Technologies announces pharmacokinetic data from phase 1 dose escalation portion of COTI-2 trial

Nov 15 (Reuters) - Critical Outcome Technologies Inc

* Critical Outcome Technologies announces pharmacokinetic data from phase 1 dose escalation portion of COTI-2 trial in gynecological malignancies Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below